Purchase 2024 Videos

Chenae Bullock Read less Chenae Bullock, LPIM, an enrolled Shinnecock Nation citizen and descendant of the Montauk Tribe in Long Island New York. She is also African American. Appearances SXSW, Forbes, Rolling Stones, TEDx, Tribal Business News, Bloomberg, Conde Nast Traveler Indian Country Today, Yahoo Finance. Chenae is the founder & CEO of Moskehtu Consulting, a cultural and heritage preservation firm. With a background in regulatory, legal, lobbying, community outreach, and development work, she assisted her tribe in establishing a successful cannabis operation through financing, planning, and more. As a licensed Indigenopathic practitioner, Chenae focuses on promoting Indigenous healthcare participation and educating on ancient Indigenous wellness practices.

Judge Mary A. Celeste (ret.) sat on the Denver County Court bench 2000-2015. She was the Presiding Judge 2009-10 and the co-founder of the Denver County Court Sobriety Court. She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and is considered a national content expert on the topic of cannabis. She is a former member of the Judicial Advisory Board for the Foundation for the Advancement of Alcohol Responsibility (FAAR); former Faculty for the National Association of Drug Court Professionals (NADCP) and the National Judicial College (NJC). She has also served as the past chair of ABA National Conference of Specialized Court Judges; the President of the American Judge’s Association and the Colorado Women’s Bar Association Foundation, and, as a National Highway Traffic Safety Administration (NHTSA) Judicial Outreach Liaison. She has written many articles and is a national speaker on the topics of cannabis; cannabis and drug impaired driving, drugged driving, and specialty courts.

The cannabis industry, burgeoning with economic potential, also faces the imperative of rectifying historical injustices wrought by prohibition. "Cannabis & Social Equity: Righting the Wrongs" convenes a distinguished panel of experts to dissect critical issues surrounding equity and inclusion within this evolving sector. Moderated by Rob Mejia, this session features esteemed panelists Scheril Murray-Powell, Tahir Johnson, Richard Washington, and Tim Brown Jr. These thought leaders will explore the intersection of cannabis legalization and social justice, providing insights into policies, practices, and initiatives aimed at ensuring marginalized communities benefit equitably from the cannabis boom. Attendees will gain a comprehensive understanding of actionable strategies and best practices necessary to foster a more inclusive and socially responsible cannabis industry.

The presentation focuses on the long and complex history of psychedelics and hemp, from their ancient use in various cultures to their modern medical and therapeutic applications, and the concomitant efforts at legalization. In doing so, we will discuss legalization efforts at the federal and state level, and the current regulatory landscape for both substances. Learning Objectives: - Discuss the history of psychedelics through the modern era. - Discuss legalization of psychedelics at the state and federal level. - Discuss current regulatory environment. - Discuss the history of hemp through the modern era. - Discuss legalization of hemp at the state and federal level. - Discuss current regulatory environment.

This Panel will discuss the existing federal policies and regulations on cannabis use by Veterans including recently passed and pending federal legislation. It will be followed by a Veterans’ Court Judge’s perspective on the use or non-use of cannabis while in a Veterans Court drug program. Along with the existing approaches that courts take on permitting or not permitting vets to use cannabis in veterans’ courts. A Study will be discussed on how Veterans are actually using marijuana as an alternative to opioids. It will conclude with a a discussions on personal stories of Veterans use of cannabis by representatives from the American Legion and Disabled Veterans of America in their respective organizations

Description: This free form conversation with Dr. Peter Grinspoon, M.D., Dr. Kevin Sabet, Shawn Hauser, Esq., Prof. Robert Mikkos, and moderator David C. Holland, Esq., will necessarily include discussion of the roots and rise of prohibition of cannabis in America as examined and explored from these perspectives and data points: 1.The history of cannabis in the colonies and United States from 1607-1936 (including its inclusion in the American Pharmacoepia from 1850-1936) 2.The social and legal factors that gave rise of prohibition embodied in the Marijuana Stamp Tax Act of 1936 and examination of the Harrison Act and early drug classifications in early 1900s 3.Studies conducted by Fiorello LaGuardia and other prominent politicians about the social benefits and/or dangers of cannabis and its need for regulation 4.U.S. Treaties and foreign policies from the 1960s that govern international obligations of member countries to interdict and prosecute drug crimes including those involving cannabis 5.The factors causing cannabis to be ‘temporarily’ placed in Schedule I under the federal Controlled Substances Act 6.The findings of the Shaeffer Commission that found cannabis did not belong in Schedule I but Nixon ordered it placed there anyhow. 7.1996 quote from White House Chief Counsel, John Ehrlichman, about the reasons for Nixon’s continuation of Schedule I status which were not based in medical concerns 8.The powers of Congress, the Executive Branch, and the administrative agencies including HHS, FDA, and DEA in the scheduling and rescheduling of cannabis 9.The rise of drug policy and policing strategies by administrative agencies, the Department of Justice, and the state and local enforcement based on federal law. 10.Legal challenges to the constitutionality of the Schedule I status of cannabis – NORML challenges – 11.Scientific and Medical justifications for continued Schedule I status – Sabet experiences and scientific bases for Schedule I continuation across 3 presidential administations 12.The implications of the legalization of medical marijuana with passage of California Compassionate Use Act of 1996 13.Legal challenges to federal prohibition from Gonzales v. Raich, through a litany of cases 14.Ogden and Cole Memoranda and Congressional sanction of the medical cannabis industry through Spending Appropriations passed every 2 years since 2014 15.Exploring the Supreme Court’s recent rulings on Cannabis including Justice Thomas certiorari dissent in Standing Akimbo LLC and whether the doctrine of Estoppel comes into play on future federal enforcement 16.International nullification of drug interdiction treaties and the modern US view of legalization 17.Studies and impacts of legalized medical and adult use cannabis programs in the states 18.The constitutional impacts of legalized medical and adult use cannabis on health insurance, transportation, worker’s compensation insurance (4 Supreme Courts split on mandatory reimbursement for medical cannabis), contracts, interstate commerce, and veteran’s benefits. 19.The short and long term effects of cannabis on consumers and economies 20.The impact of rescheduling vs. descheduling cannabis Learning Objectives: Exploring the legal, medical, and social ramifications of the proposed rescheduling of cannabis under the federal Controlled Substances Act. Through a free form dialogue supported by various learning materials, studies, law review articles, and legal briefs, attendees will become intimately familiar with: A.The history of cannabis in the colonies and United States, B. The roots and rise of prohibition in 1936, C.The counterculture movement and passage of the federal Controlled Substances Act of 1970 D.Statistical and legal analysis of prohibition from 1970-present day E.The challenges to prohibition and the evolution of federal tolerance for state medical and adult use programs F.The utility and validity of state and international medical studies conducted outside the strictures of the federal Controlled Substances Act G.The impact of rescheduling vs descheduling cananbis. H.What lies ahead for cannabis on the continent as neighboring nations legalize on a national level?

This Panel will discuss the following: 1. General Overview of Cannabis and its Laws a. Cannabis market and its growth b. Federal Legal Status c. Legal status across states i. recreational, medical, some legal use 2. Federal vs. State Law a. Exemptions to state protections 3. A Glimpse into Noteworthy States a. California b. Illinois c. Nevada d. New York e. Texas Learning Objectives: The audience will learn about the new implications that cannabis use poses for both employers and employees. The audience will learn a general overview of various employment protections for employees who use cannabis.

This Panel will first discuss the DRE Program and how states are treating the admissibility of DRE testimony whether it be under a Frye, Daubert, 702 analyses, or by a statutory scheme. It will also review the DRE Protocol from a law enforcement perspective. Lastly it addresses the issues encountered by defense attorneys and prosecutors when conducting direct and cross examination testimony of the DRE from the perspective of a NHTSA Training Resource Prosecutor and a defense attorney with an expertise in impaired driving.

Joseph Rosado MD is a leading Physician as well as a well-respected Medical Director, educator, published author, and prominent public speaker. His extensive experience in the broad field of Integrative Medicine combined with his unique specializations ensure he can provide a comprehensive level of high-quality care for all members of your family.Dr. Joseph Rosado is one of the United States’ most well-respected scientists working with Medical Cannabis. He has been regularly featured on major US TV networks as a guest speaker. Dr. Rosado is fluent in English and Spanish. Further, he has been invited to speak all over the world educating doctors including but not limited to these countries: Fiji, Malaysia, Italy, and Costa Rica.